Introduction Phosphatidylethanolamine (PE)-conjugated nanoliposomes were developed,
characterized, and investigated for their accumulation in liver, kidneys, and lungs in rats …

Among the various drug delivery devices, nanoliposome is an emerging formulation in the
treatment of cancer. Here we have developed tamoxifen citrate (TC) loaded nanoliposome …

Background Colorectal cancer is one of the prominent leading causes of fatality worldwide.
Despite recent advancements within the field of cancer therapy, the cure rates and long-term …

Background: Chemotherapy for non-small-cell lung cancer (NSCLC) still leads to
unsatisfactory clinical prognosis because of poor active targeting and tumor metastasis …

Tumor specific delivery of anti‐cancer drugs is one of the major challenges faced by drug
development processes. In this study, we prepared a doxorubicin (DOX)‐conjugated …

Liposome-based drug delivery systems hold great potential for cancer therapy. However, to
enhance the localization of payloads, an efficient method of systemic delivery of liposomes …

Background/aim: This study aimed to investigate the efficacy of pegylated liposomal
etoposide nanoparticles (NPs) against T-47D and MCF-7 breast cancer cell lines. Materials …

The PEGylated liposomal nanoparticle has been widely used as a carrier in drug delivery
system. To become biologically active, the encapsulated drug must be released from the …

Neutral liposomes (NLP) exhibit preferential localization in solid tumors based on the
enhanced permeation and retention (EPR) effect. Cationic liposomes (CLP) have a …

Background Oleanolic acid is a pentacyclic triterpene present in many fruits and vegetables,
and has received much attention on account of its biological properties. However, its poor …